BioSpace News Archive

PositiveID’s ExcitePCR Subsidiary Publishes White Paper: PCR Unchained: The Coming Revolution in Field-Based Pathogen Detection

Company projects that a product like ExcitePCR’s FireflyDX could transform the $28 billion global point-of-care diagnostics market.

October 24, 2017

·

5 min read

Business

BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization

The Company has engaged Quintain Project Solutions LLC as the manufacturing project management leader for the PURE EP System.

October 24, 2017

·

4 min read

BioMidwest

SonarMed Completes $3M Series C Preferred Stock Financing

Proceeds support ongoing controlled market roll-out and launch of the AirWave Monitoring System for pediatric patients.

October 24, 2017

·

2 min read

Pharm Country

Cognition Therapeutics Announces Issuance of Broad Composition of Matter Patent for CT1812, a First-in-Class Alzheimer’s Disease Clinical Candidate

The newly issued patent provides Cognition with protection for CT1812 in the United States through 2034.

October 24, 2017

·

3 min read

Biotech Bay

Global Blood Therapeutics Announces Approval of First-in-Class ‘Voxelotor’ as Nonproprietary Name for GBT440

Voxelotor is an oral, once-daily therapy that is designed to modulate hemoglobin affinity for oxygen and is in clinical development for the treatment of sickle cell disease.

October 24, 2017

·

5 min read

Business

Care Innovations and PRA Health Sciences Announce Strategic Partnership

As part of Care Innovations focus on expanding into adjacent markets, the company is proud to announce its exclusive global partnership with PRA Health Sciences.

October 24, 2017

·

3 min read

Business

Tumor Antigen 5T4 Associated With Many Forms of Solid Tumors Identified as the Second Target for ALG.APV-527 – a Novel Bispecific Antibody Candidate Being Developed by Alligator Bioscience and Aptevo Therapeutics

Alligator and Aptevo have created a drug candidate whose effect is localized to the tumor area, activating the tumor-specific immune cells present there.

October 24, 2017

·

5 min read

Drug Development

Molecular Templates Announces Dosing of First Patient in Phase 1 Expansion Study of MT-3724 in Diffuse Large B-Cell Lymphoma (DLBCL)

October 24, 2017

·

3 min read

Biotech Bay

Anthera Pharmaceuticals Announces Pricing of $15M Private Placement Offering

The PIPE is expected to have two closings.

October 24, 2017

·

4 min read

Business

Alphatec Announces Preliminary Third Quarter 2017 Financial Results and Corporate Updates

The Company also announced several corporate updates.

October 24, 2017

·

8 min read